Takeda Pushes Meijer Antitrust Suit Into Arbitration
By Nadia Dreid · January 27, 2025, 9:04 PM EST
Meijer is going to have to arbitrate its claims that Takeda Pharmaceutical broke antitrust law by cutting a pay-for-delay deal with Par Pharmaceuticals to keep a generic version of Takeda's anti-constipation...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login